{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:57:50Z","timestamp":1791644270112,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011840","name":"Shantou University Medical College","doi-asserted-by":"publisher","award":["350 510859066"],"award-info":[{"award-number":["350 510859066"]}],"id":[{"id":"10.13039\/501100011840","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.intimp.2024.112847","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T14:12:33Z","timestamp":1722435153000},"page":"112847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Advancement in the development of DNA vaccines against Trypanosoma brucei and future perspective"],"prefix":"10.1016","volume":"140","author":[{"given":"Muhammad","family":"Tahir Aleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furqan","family":"Munir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Shakoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia","family":"ud Din Sindhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenfei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112847_b0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.intimp.2024.112847_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011269","article-title":"The Trypanosoma brucei MISP family of invariant proteins is co-expressed with BARP as triple helical bundle structures on the surface of salivary gland forms, but is dispensable for parasite development within the tsetse vector","volume":"19","author":"Casas-Sanchez","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2024.112847_b0015","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","article-title":"Human African trypanosomiasis","volume":"390","author":"B\u00fcscher","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.112847_b0020","doi-asserted-by":"crossref","DOI":"10.1186\/1756-3305-1-3","article-title":"The history of African trypanosomiasis","volume":"1","author":"Steverding","year":"2008","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.intimp.2024.112847_b0025","first-page":"257","article-title":"Epidemiology of human African trypanosomiasis","volume":"6","author":"Franco","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.intimp.2024.112847_b0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1473-3099(02)00321-3","article-title":"Treatment of human African trypanosomiasis - Present situation and needs for research and development","volume":"2","author":"Legros","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.intimp.2024.112847_b0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.exppara.2010.06.017","article-title":"Trypanosoma brucei: immunisation with plasmid DNA encoding invariant surface glycoprotein gene is able to induce partial protection in experimental African trypanosomiasis","volume":"127","author":"Lan\u00e7a","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.intimp.2024.112847_b0040","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/389153","article-title":"Immunobiology of African trypanosomes: need of alternative interventions","volume":"2010","author":"Baral","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.intimp.2024.112847_b0045","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1126\/science.1112642","article-title":"The genome of the African trypanosome Trypanosoma brucei","volume":"309","author":"Berriman","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.intimp.2024.112847_b0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.micpath.2011.01.011","article-title":"In silico identification of novel protective VSG antigens expressed by Trypanosoma brucei and an effort for designing a highly immunogenic DNA vaccine using IL-12 as adjuvant","volume":"51","author":"Akhoon","year":"2011","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.intimp.2024.112847_b0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-2-8178-0857-4_7","article-title":"Cytokines in the pathogenesis of human African trypanosomiasis: antagonistic roles of TNF-\u03b1 and IL-10","author":"Rhind","year":"1999","journal-title":"Prog. Hum. African Trypanos. Sleep. Sick."},{"key":"10.1016\/j.intimp.2024.112847_b0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.vetpar.2012.01.009","article-title":"Induction of protective immune response in mice by a DNA vaccine encoding Trypanosoma evansi beta tubulin gene","volume":"187","author":"Kurup","year":"2012","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.intimp.2024.112847_b0065","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3285","article-title":"Tools to therapeutically harness the human antibody response","volume":"12","author":"Wilson","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112847_b0070","article-title":"Review Article Rationale to Develop mRNA-based Vaccines for Trypanosoma brucei (a review) Review Article Rationale to Develop mRNA-based Vaccines for Trypanosoma brucei (a review)","author":"Munir","year":"2023","journal-title":"Cont. Vet. J."},{"key":"10.1016\/j.intimp.2024.112847_b0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1387-2656(04)10007-0","article-title":"DNA vaccines and their application against parasites - Promise, limitations and potential solutions","volume":"10","author":"Smooker","year":"2004","journal-title":"Biotechnol. Annu. Rev."},{"key":"10.1016\/j.intimp.2024.112847_b0080","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S2221-1691(15)30366-X","article-title":"The past, current and future trends in DNA vaccine immunisations, Asian Pac","volume":"5","author":"Hasson","year":"2015","journal-title":"J Trop. Biomed."},{"key":"10.1016\/j.intimp.2024.112847_b0085","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.intimp.2024.112847_b0090","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/356152a0","article-title":"Genetic immunization is a simple method for eliciting an immune response","volume":"356","author":"Tang","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.112847_b0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0065-2660(05)54011-2","article-title":"DNA vaccine","volume":"54","author":"Cui","year":"2005","journal-title":"Adv. Genet."},{"key":"10.1016\/j.intimp.2024.112847_b0100","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology, application, and optimization*","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112847_b0105","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/1535370216643771","article-title":"Micro- and nanoparticulates for DNA vaccine delivery","volume":"241","author":"Farris","year":"2016","journal-title":"Exp. Biol. Med. (maywood)"},{"key":"10.1016\/j.intimp.2024.112847_b0110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/AIHB.AIHB_74_17","article-title":"DNA vaccine: Methods and mechanisms","volume":"8","author":"Soltani","year":"2018","journal-title":"Adv. Hum. Biol."},{"key":"10.1016\/j.intimp.2024.112847_b0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/erv.11.188","article-title":"Technologies for enhanced efficacy of DNA vaccines","volume":"11","author":"Saade","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.intimp.2024.112847_b0120","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1166\/jbn.2014.1981","article-title":"Nanoparticles for DNA vaccine delivery","volume":"10","author":"Shah","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.intimp.2024.112847_b0125","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1586\/14760584.3.4.453","article-title":"Antigen delivery systems","volume":"3","author":"Kersten","year":"2004","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.intimp.2024.112847_b0130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejps.2005.03.013","article-title":"Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles","volume":"25","author":"Galindo-Rodr\u00edguez","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2024.112847_b0135","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1073\/pnas.97.2.811","article-title":"Cationic microparticles: A potent delivery system for DNA vaccines","volume":"97","author":"Singh","year":"2000","journal-title":"Proc. Natl. Acad. Sci. u. s. a."},{"key":"10.1016\/j.intimp.2024.112847_b0140","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.biomaterials.2009.11.100","article-title":"Multifunctional core-shell polymeric nanoparticles for transdermal DNA delivery and epidermal Langerhans cells tracking","volume":"31","author":"Lee","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2024.112847_b0145","first-page":"1644","article-title":"Chitosan-based particulate systems for drug and vaccine delivery in the treatment and prevention of neglected tropical diseases, Drug Deliv","volume":"10","author":"\u015eenel","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.intimp.2024.112847_b0150","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/bc020051g","article-title":"N-alkylated chitosan as a potential nonviral vector for gene transfection","volume":"14","author":"Liu","year":"2003","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.intimp.2024.112847_b0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.addr.2008.12.014","article-title":"Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy","volume":"61","author":"Wilson","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.intimp.2024.112847_b0160","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.nano.2013.12.003","article-title":"Cationic lipid nanocarriers activate Toll-like receptor 2 and NLRP3 inflammasome pathways","volume":"10","author":"Lonez","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.intimp.2024.112847_b0165","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1158\/1078-0432.CCR-04-2482","article-title":"Antiangiogenic properties of gold nanoparticles","volume":"11","author":"Mukherjee","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2024.112847_b0170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1097-2765(02)00571-3","article-title":"Multiple mitochondrial DNA polymerases in Trypanosoma brucei","volume":"10","author":"Klingbeil","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2024.112847_b0175","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pt.2006.02.006","article-title":"The evolution and diversity of kinetoplastid flagellates","volume":"22","author":"Simpson","year":"2006","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.intimp.2024.112847_b0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vetpar.2007.05.005","article-title":"African trypanosomosis: from immune escape and immunopathology to immune intervention","volume":"148","author":"Stijlemans","year":"2007","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.intimp.2024.112847_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005259","article-title":"How Does the VSG Coat of Bloodstream Form African Trypanosomes Interact with External Proteins?","volume":"11","author":"Schwede","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2024.112847_b0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.molbiopara.2010.11.004","article-title":"The VSG C-terminal domain is inaccessible to antibodies on live trypanosomes","volume":"175","author":"Schwede","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.intimp.2024.112847_b0195","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1017\/S0031182009992034","article-title":"Bloodstream form Trypanosome plasma membrane proteins: antigenic variation and invariant antigens","volume":"137","author":"Schwede","year":"2010","journal-title":"Parasitology"},{"key":"10.1016\/j.intimp.2024.112847_b0200","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0001-706X(02)00237-1","article-title":"Antigenic variation and the African trypanosome genome","volume":"85","author":"Donelson","year":"2003","journal-title":"Acta Trop."},{"key":"10.1016\/j.intimp.2024.112847_b0205","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1292\/jvms.71.313","article-title":"Both type-I and type-II responses contribute to murine trypanotolerance","volume":"71","author":"Namangala","year":"2009","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.intimp.2024.112847_b0210","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00436-009-1542-6","article-title":"Trans-sialidase from Trypanosoma brucei as a potential target for DNA vaccine development against African trypanosomiasis","volume":"105","author":"Silva","year":"2009","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.intimp.2024.112847_b0215","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1128\/IAI.69.4.2162-2171.2001","article-title":"DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide","volume":"69","author":"Shoda","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2024.112847_b0220","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1586\/erv.09.158","article-title":"DNA vaccines: a rational design against parasitic diseases","volume":"9","author":"Carvalho","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.intimp.2024.112847_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pathogens10081050","article-title":"The history of anti-trypanosome vaccine development shows that highly immunogenic and exposed pathogen-derived antigens are not necessarily good target candidates: Enolase and isg75 as examples","volume":"10","author":"Magez","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.intimp.2024.112847_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00582","article-title":"African Trypanosomes Undermine Humoral Responses and Vaccine Development: Link with Inflammatory Responses?","volume":"8","author":"Stijlemans","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112847_b0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005733","article-title":"Trypanosoma brucei Co-opts NK Cells to Kill Splenic B2 B Cells","volume":"12","author":"Frenkel","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2024.112847_b0240","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.cell.2007.08.046","article-title":"Hydrodynamic flow-mediated protein sorting on the cell surface of trypanosomes","volume":"131","author":"Engstler","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.112847_b0245","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.micinf.2005.11.009","article-title":"CR3 (CD11b\/CD18) is the major macrophage receptor for IgM antibody-mediated phagocytosis of African trypanosomes: diverse effect on subsequent synthesis of tumor necrosis factor alpha and nitric oxide","volume":"8","author":"Pan","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.intimp.2024.112847_b0250","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-4017(02)00363-1","article-title":"The effect of Trypanosoma evansi infection on pig performance and vaccination against classical swine fever","volume":"111","author":"Holland","year":"2003","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.intimp.2024.112847_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004414","article-title":"MIF contributes to Trypanosoma brucei associated immunopathogenicity development","volume":"10","author":"Stijlemans","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2024.112847_b0260","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12664","article-title":"Trypanosoma brucei brucei causes a rapid and persistent influx of neutrophils in the spleen of infected mice","volume":"41","author":"Deleeuw","year":"2019","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.intimp.2024.112847_b0265","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1016\/j.csbj.2022.10.002","article-title":"Immunoinformatic design of a putative multi-epitope vaccine candidate against Trypanosoma brucei gambiense","volume":"20","author":"Danazumi","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.intimp.2024.112847_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109394","article-title":"Lit-LAMP-DNA-vaccine for shrimp allergy prevents anaphylactic symptoms in a murine model","volume":"113","author":"Kubo","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112847_b0275","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.167","article-title":"mRNA vaccines in the prevention and treatment of diseases","volume":"3","author":"Gu","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.intimp.2024.112847_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112320","article-title":"mRNA vaccines against infectious diseases and future direction","volume":"135","author":"Aleem","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112847_b0285","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2478\/jtim-2023-0122","article-title":"Circular RNA: A promising new star of vaccine","volume":"11","author":"Xie","year":"2023","journal-title":"J. Transl. Intern. Med."},{"key":"10.1016\/j.intimp.2024.112847_b0290","doi-asserted-by":"crossref","first-page":"2202921","DOI":"10.1002\/adhm.202202921","article-title":"Biodegradable Microrobots for DNA Vaccine Delivery","volume":"12","author":"Chen","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.intimp.2024.112847_b0295","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jbiotec.2012.08.012","article-title":"The future of human DNA vaccines","volume":"162","author":"Li","year":"2012","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.intimp.2024.112847_b0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-1759(99)00104-0","article-title":"Nucleic acid immunization: Concepts and techniques associated with third generation vaccines","volume":"229","author":"Hasan","year":"1999","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.intimp.2024.112847_b0305","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.molbiopara.2007.03.012","article-title":"Functional genomics in Trypanosoma brucei: a collection of vectors for the expression of tagged proteins from endogenous and ectopic gene loci","volume":"154","author":"Kelly","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.intimp.2024.112847_b0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205527","article-title":"Simplified inducible system for Trypanosoma brucei","volume":"13","author":"Niemirowicz","year":"2018","journal-title":"PLoS One"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924013687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924013687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:08:41Z","timestamp":1786363721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924013687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":62,"alternative-id":["S1567576924013687"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112847","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancement in the development of DNA vaccines against Trypanosoma brucei and future perspective","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112847"}}